Utopia Medical Oy is a limited company based in Espoo, registered in 2021. In the financial year ending 31.12.2025, revenue was 154 t€ and operating profit 37 t€; equity ratio 99.3 %. Its taxable income in 2024 was 145 t€ and its income taxes 29 t€.
Revenue 2025154 t€-50 % on the previous year
Operating profit37 t€24,0 % of revenue
Net profit38 t€EBITDA 37 t€
Equity ratio99,3 %quick ratio 65,46
Taxable income 2024145 t€
upper half of its industry
Income taxes 202429 t€99 t€ in 2022–2024
In business5 yrsregistered 11.10.2021
Espoo: 106 new companies in 30 days
- Ilovite OyOhjelmistojen suunnittelu ja valmistus
- Kahvila Tuisku OyKahvilat ja muu alkoholittomien juomien tarjoilu
- Mizero OyErikoistumaton agentuuritoiminta
Try for free
Get your area's new companies by email every morning. 14 days, no card needed.
Financials
RevenueOperating profitNet profit
| Key figures | 31.12.2025 | 31.12.2024 |
|---|---|---|
| Revenue | 154 t€ | 311 t€ |
| Revenue change | -50,5 % | – |
| EBITDA | 37 t€ | 142 t€ |
| EBITDA % | 23,8 % | 45,7 % |
| Operating profit | 37 t€ | 143 t€ |
| Operating margin | 24,0 % | 45,9 % |
| Net profit | 38 t€ | 115 t€ |
| Personnel costs | -81 t€ | -134 t€ |
| Equity ratio | 99,3 % | 93,8 % |
| Quick ratio | 65,46 | 8,58 |
| Current ratio | 136,93 | 16,12 |
| Debt to revenue | 1,7 % | 7,6 % |
| Return on equity | 10,3 % | 32,1 % |
| Balance sheet total | 369 t€ | 381 t€ |
| Equity | 367 t€ | 357 t€ |
| Cash and bank | 23 t€ | 147 t€ |
Balance sheet
Balance sheet totalEquityCash
Income statement and balance sheet
Income statement
| 31.12.2025 | 31.12.2024 | |
|---|---|---|
| Turnover | 154 t€ | 311 t€ |
| Raw materials and services | 1 168 € | 0 € |
| Personnel expenses | 81 t€ | 134 t€ |
| Depreciations and reductions in value | 381 € | 507 € |
| Other operating expenses | 34 t€ | 34 t€ |
| Operating profit (loss) | 37 t€ | 143 t€ |
| Financial income and expenses + (-) | -9 875 € | -1 099 € |
| Profit (loss) before appropriations and taxes | 47 t€ | 144 t€ |
| Income taxes | 9 061 € | 29 t€ |
| Profit (loss) for the financial year | 38 t€ | 115 t€ |
Balance sheet
| 31.12.2025 | 31.12.2024 | |
|---|---|---|
| Non-current assets | 1 142 € | 1 522 € |
| Stocks | 192 t€ | 177 t€ |
| Receivables | 27 t€ | 6 631 € |
| Cash in hand and at banks | 23 t€ | 147 t€ |
| Current assets | 368 t€ | 379 t€ |
| Assets | 369 t€ | 381 t€ |
| Capital and reserves | 367 t€ | 357 t€ |
| Short-term liabilities | 2 690 € | 24 t€ |
| Liabilities | 2 690 € | 24 t€ |
All financial statement items (43)
| 31.12.2025 | 31.12.2024 | |
|---|---|---|
| Turnover | 154 t€ | 311 t€ |
| Raw materials and services | 1 168 € | 0 € |
| Personnel expenses | 81 t€ | 134 t€ |
| Depreciations and reductions in value | 381 € | 507 € |
| Other operating expenses | 34 t€ | 34 t€ |
| Operating profit (loss) | 37 t€ | 143 t€ |
| Financial income and expenses + (-) | -9 875 € | -1 099 € |
| Profit (loss) before appropriations and taxes | 47 t€ | 144 t€ |
| Income taxes | 9 061 € | 29 t€ |
| Profit (loss) for the financial year | 38 t€ | 115 t€ |
| Non-current assets | 1 142 € | 1 522 € |
| Stocks | 192 t€ | 177 t€ |
| Receivables | 27 t€ | 6 631 € |
| Cash in hand and at banks | 23 t€ | 147 t€ |
| Current assets | 368 t€ | 379 t€ |
| Assets | 369 t€ | 381 t€ |
| Capital and reserves | 367 t€ | 357 t€ |
| Short-term liabilities | 2 690 € | 24 t€ |
| Liabilities | 2 690 € | 24 t€ |
| Other current liabilities | 2 690 € | 3 945 € |
| Retained earnings | 329 t€ | 243 t€ |
| Long-term receivables | 15 t€ | 1 650 € |
| Short-term prepayments and accrued income | 2 642 € | 0 € |
| Other long-term receivables | 0 € | 1 650 € |
| Short-term sales receivables | 9 845 € | 4 981 € |
| Purchases during the financial year | 16 t€ | 0 € |
| Profit (loss) for the period, equity | 38 t€ | 115 t€ |
| Long-term loan receivables | 15 t€ | 0 € |
| Short-term receivables | 12 t€ | 4 981 € |
| Interest expenses and other financial expenses for non-Group companies | 720 € | 0 € |
| Tangible assets | 1 142 € | 1 522 € |
| Wages and salaries | 72 t€ | 123 t€ |
| Short-term accrued expenses and deferred income | 0 € | 20 t€ |
| Other shares, financial securities | 126 t€ | 49 t€ |
| Liabilities | 369 t€ | 381 t€ |
| Other interest and financial income from non-group companies | 11 t€ | 1 099 € |
| Other social security expenses | 1 346 € | 3 199 € |
| Machinery and equipment | 1 142 € | 1 522 € |
| Shares and holdings | 126 t€ | 49 t€ |
| Other stocks | 192 t€ | 177 t€ |
| Depreciations according to plan | 381 € | 507 € |
| Inventory increase (+) or decrease (-) | -15 t€ | 0 € |
| Pension expenses | 8 328 € | 7 928 € |
From financial statements filed digitally (XBRL) with the Finnish Patent and Registration Office; ratios calculated from them. Equity ratio = (equity + accumulated appropriations) / (balance sheet total − advances received).
Taxes
Measured by taxable income, Utopia Medical Oy is in the upper half of the industry class medical specialists activities (2077 companies with taxable income; median 81 t€).
Taxable income is the profit as calculated for taxation, not revenue. Public data from the Finnish Tax Administration; figures for 2025 are published in November 2026.